Stability‐indicating method development and validation for quantitative estimation of organic impurities of the antidiabetic drug glipizide in drug substance and pharmaceutical dosage form using HPLC
Biomedical Chromatography · 2023
DOI: 10.1002/bmc.5727 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2023. Verfasst von Bhujanga Rao Nagulancha und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, GITAM School of Science, Hyderabad, India. Hauptthemen laut MEDLINE: Glipizide, Hypoglycemic Agents, Drug Contamination. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Glipizide is an antidiabetic drug used for the treatment of type 2 diabetes. A simple, reliable and robust reverse‐phase liquid chromatographic method (RP‐HPLC) was developed and validated as per International Conference on Harmonization Q2(R1) for estimating the impurities of glipizide in pharmaceutical formulations. The chromatographic separation was carried out on a Phenomenex Luna C 18 (2) , 250 × 4.6 mm, 5 μm with a binary solvent delivery system [MP‐A, a homogenous mixture of water and acetonitrile in a ratio of 90:10 (v/v) and 1 ml of orthophosphoric acid; and MP‐B, a homogenous mixture of water and acetonitrile in a ratio of 10:90 (v/v) and 1 ml of orthophosphoric acid] with a detection wavelength of 225 nm, a column temperature of 30°C, a flow rate of 1.5 ml/min, and an injection volume of 20 μl. All process, degradant and unknown impurities were separated well with a resolution >2.2 and were estimated accurately without any interference. The recovered values and regression values were 98.7–100.5% and R 2 > 0.9999, respectively. The recovery and linearity studies covered the quantitation limit to 150% of the specification limit. The stability‐indicating properties of the developed RP‐HPLC method was assessed from the forced degradation studies. The developed method was successfully applied for real‐time sample analysis of the glipizide dosage form.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, GITAM School of Science, Hyderabad, India.
ORCID-Profile: Bhujanga Rao Nagulancha, Koteswara Rao Vandavasi
Zitieren
APA
Nagulancha, B. R., & Vandavasi, K. R. (2023). Stability‐indicating method development and validation for quantitative estimation of organic impurities of the antidiabetic drug glipizide in drug substance and pharmaceutical dosage form using HPLC. Biomedical Chromatography. https://doi.org/10.1002/bmc.5727
Vancouver
Nagulancha BR, Vandavasi KR. Stability‐indicating method development and validation for quantitative estimation of organic impurities of the antidiabetic drug glipizide in drug substance and pharmaceutical dosage form using HPLC. Biomedical Chromatography. 2023. doi:10.1002/bmc.5727
BibTeX
@article{Nagulancha2023,
author = {Nagulancha, Bhujanga Rao and Vandavasi, Koteswara Rao},
title = {Stability‐indicating method development and validation for quantitative estimation of organic impurities of the antidiabetic drug glipizide in drug substance and pharmaceutical dosage form using HPLC},
journal = {Biomedical Chromatography},
year = {2023},
doi = {10.1002/bmc.5727}
}
EUVIMED